Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3763 3783
This examiner grants 86% of resolved cases
Manuel A. Mendez is an examiner in Art Unit 3763 of Tech Center 3700, with a volume of 1248 resolved cases. The allowance rate is 86.0 percent, indicating a high frequency of successful outcomes for applicants. The interview lift is 8.5 percent, showing a positive benefit from direct communication with the examiner compared to the 86.0 percent baseline. This 8.5 percent lift suggests that while not always necessary, interviews can help resolve lingering issues.
The median pendency for allowed applications is 1060 days. This 1060 day figure, combined with the 86.0 percent allowance rate, suggests a predictable path to issuance. Practitioners should note that while the 8.5 percent lift is positive, the base allowance rate of 86.0 percent means success is often achieved through standard written prosecution. The 1248 resolved cases demonstrate extensive experience within Tech Center 3700. The 1060 day timeline is a reliable benchmark for planning purposes in Art Unit 3763.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18650193 | FLUID MIXING DEVICES AND METHODS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18720738 | BREAST PUMP SYSTEM | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18745159 | MEDICATION DELIVERY DEVICE WITH GEAR SET DOSAGE SYSTEM | Non-Final OA | Eli Lilly and Company |
| 18666702 | SECURE PATIENT-CONTROLLED ANALGESIA | Non-Final OA | CareFusion 303, Inc. |
| 18391561 | MEDICAL DEVICE ADAPTIVE CONTROL FOR HOSTILE ENVIRONMENT | Non-Final OA | CareFusion 303, Inc. |
| 18677611 | ARTERIAL HEMOSHIELD DEVICE FOR ARTERIAL BLOOD DRAW AND RELATED METHODS | Non-Final OA | Becton, Dickinson and Company |
| 18613659 | Needle Guard Assembly for Fluid Removal From a Glass Ampoule | Non-Final OA | Becton, Dickinson and Company |
| 18226036 | IV MEMBRANE ATTACHMENT SYSTEMS AND METHODS | Non-Final OA | Becton, Dickinson and Company |
| 18706097 | DRUG DELIVERY DEVICE | Non-Final OA | Sanofi |
| 18781693 | SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERY | Non-Final OA | Insulet Corporation |
| 18661020 | METHODS TO DEMONSTRATE PROGRESS TOWARDS FULL ADAPTATION AND TO PRESENT POTENTIAL IMPROVEMENTS THROUGH BEHAVIORAL CHANGES | Non-Final OA | INSULET CORPORATION |
| 18638195 | INSULIN DELIVERY METHODS, SYSTEMS AND DEVICES | Non-Final OA | Insulet Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy